VIOSERA THERAPEUTICS
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria. The company discovers synergies between approved drugs and develop combinations of drugs that suppress resistance. Antibiotic resistance makes it necessary to develop better treatments for deadly infections. Viosera Therapeutics was founded in July 2016 and is headquartered in Sunnyvale, California.
VIOSERA THERAPEUTICS
Industry:
Medical Pharmaceutical Therapeutics Wellness
Founded:
2016-07-01
Address:
Saint Louis, Missouri, United States
Country:
United States
Website Url:
http://www.viosera.com
Total Employee:
1+
Status:
Active
Total Funding:
150 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Squarespace Hosted
Similar Organizations
Allorion Therapeutics
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
Founder
Investors List
Pioneer Fund
Pioneer Fund investment in Seed Round - Viosera Therapeutics
UpHonest Capital
UpHonest Capital investment in Seed Round - Viosera Therapeutics
Brightstone Venture Capital
Brightstone Venture Capital investment in Seed Round - Viosera Therapeutics
SV Angel
SV Angel investment in Pre Seed Round - Viosera Therapeutics
Y Combinator
Y Combinator investment in Pre Seed Round - Viosera Therapeutics
Endpoint Ventures
Endpoint Ventures investment in Pre Seed Round - Viosera Therapeutics
Liquid 2 Ventures
Liquid 2 Ventures investment in Pre Seed Round - Viosera Therapeutics
Pioneer Fund
Pioneer Fund investment in Pre Seed Round - Viosera Therapeutics
St. Louis Arch Angels
St. Louis Arch Angels investment in Pre Seed Round - Viosera Therapeutics
Official Site Inspections
http://www.viosera.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Viosera Therapeutics"
Viosera Therapeutics - Crunchbase Company Profile & Funding
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria. The company discovers synergies between approved drugs and develop combinations of drugs that …See details»
Viosera Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Viosera. Use the PitchBook Platform to explore the full profile.See details»
Viosera Therapeutics, Inc. Company Profile | Saint Louis, MO ...
Find company research, competitor information, contact details & financial data for Viosera Therapeutics, Inc. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
ResistanceBio: We solve drug resistance for cancer - Y …
Founded Viosera Therapeutics to develop resistance-proof antimicrobial drugs and founded resistanceBio to help pharma avoid drug resistance in cancer. I have a PhD in molecular cell biology, I figure out how living cells thrive in hostile …See details»
Viosera Therapeutics - Craft
Viosera Therapeutics is a company developing combination therapies for infections and cancer. It specializes in resistance-suppressing combinations of FDA approved antibiotics.See details»
Viosera Therapeutics Headquarters and Office Locations - Craft
Viosera Therapeutics is headquartered in Overland, 1912 Innerbelt Business Center Dr, United States, and has 1 office location.See details»
Portfolio | Sahsen
St. Louis-based Viosera is a pre-clincial drug development company formed by Chris Bulow and Nick Goldner in July 2016 as a platform to study and treat drug resistance diseases such as …See details»
Viosera Therapeutics - VentureRadar
We solve drug resistance for cancer and antibiotics. ... Find out more about Viosera Therapeutics, AI-powered Drug Discovery.See details»
Viosera Therapeutics - Funding, Financials, Valuation & Investors
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.See details»
Viosera Therapeutics - Products, Competitors, Financials, …
Viosera Therapeutics uses AI to predict and block drug resistance in cancer and bacteria. It was founded in 2016 and is based in Saint Louis, Missouri. You're one click away from the most …See details»
Viosera Therapeutics - Contacts, Employees, Board Members
Viosera Therapeutics has 3 current employee profiles, including Chief Scientific Officer Aki Kau. Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.See details»
Christopher BULOW | COO | Doctor of Philosophy | Research profile
Co-founder at Viosera Therapeutics developing treatment strategies to combat resistance evolution in bacteria and cancer.See details»
Pharmacokinetics, Tissue Distribution, and Efficacy of VIO-001 ...
Oct 18, 2021 · VIO-001 is a formulation developed by Viosera Therapeutics as a combination of MER, PIP, and TAZ at a ratio that covers clinical MRSA isolates with a variety of resistance …See details»
Get to Know the 2017 GIA Finalists: Viosera | Skandalaris Center for ...
Sep 11, 2017 · Viosera Therapeutics is developing a new therapy for Americans with Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections. They are in desperate need …See details»
VIO-001 - Drug Targets, Indications, Patents - Synapse
Nov 21, 2024 · OBJECTIVES To meta-analyse the clinical efficacy of piperacillin-tazobactam vs. carbapenems for treating hospitalized patients affected by extended-spectrum beta-lactamase …See details»
Viosera Therapeutics - Tech Stack, Apps, Patents & Trademarks
Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.See details»
In vitro activity of meropenem/piperacillin/tazobactam triple ...
Feb 1, 2020 · To evaluate the activity of the reported synergistic and collaterally sensitive antibiotic combination, meropenem/piperacillin/tazobactam (ME/PI/TZ), against a panel of …See details»
DCIS genomic signatures define biology and correlate with
Jul 24, 2021 · We made observations on DNA, RNA, and protein expression, and generated a de novo clustering scheme for DCIS that represents a fundamental transcriptomic organization at …See details»
Top Viosera Therapeutics Competitors and Alternatives - Craft
Viosera Therapeutics's main competitors include Allucent TX, Tetherex, Medivir and Lava Therapeutics. Compare Viosera Therapeutics to its competitors by revenue, employee growth …See details»
Maven Repository: org.jsoup » jsoup » 1.18.2
1 day ago · jsoup is a Java library that simplifies working with real-world HTML and XML. It offers an easy-to-use API for URL fetching, data parsing, extraction, and manipulation using DOM …See details»